Serial Therapy-Induced Changes in Tumor Shape in Cervical Cancer and Their Impact on Assessing Tumor Volume and Treatment Response
- 1 July 2006
- journal article
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 187 (1) , 65-72
- https://doi.org/10.2214/ajr.05.0039
Abstract
OBJECTIVE. The purpose of this study was to evaluate the patterns and distribution of tumor shape and its temporal change during radiation therapy (RT) in cervical cancer and the effect of tumor configuration changes on the correlation between region of interest (ROI)-based and diameter-based MRI tumor measurement. MATERIALS AND METHODS. Serial MRI examinations (T1-weighted and T2-weighted images) were performed in 60 patients (age range, 29-75 years; mean, 53.3 years) with advanced cervical cancer (stages IB2-IVB/recurrent) who were treated with RT at four time points: start of RT, during RT (at 2-2.5 and at 4-5 weeks of RT), and post-RT. Tumor configuration was classified qualitatively into oval, lobulated, and complex based on MR film review. Two methods of tumor volume measurement were compared: ellipsoid computation of three orthogonal diameters (diameter based) and ROI volumetry by delineating the entire tumor volume on the MR workstation (ROI based). Temporal changes of tumor shape and the respective tumor volumes measured by the two methods were analyzed using linear regression analysis. RESULTS. Most tumors (70%) had a non-oval (lobulated and complex) shape before RT and became increasingly irregular during and after RT: 84% at 2-2.5 weeks of RT (p = 0.037), 86% (p = 0.025) at 4-5 weeks, and 96% post-RT (p = 0.010), compared with 70% pre-RT. Diameter-based and ROI-based measurement correlated well before RT (r = 0.89) but not during RT (r = 0.68 at 2-2.5 weeks, r = 0.67 at 4-5 weeks of RT). CONCLUSION. Most cervical cancers are not oval in shape pretherapy, and they become increasingly irregular during and after therapy because of nonconcentric tumor shrinkage. ROI-based volumetry, which can optimally measure irregular volumes, may provide better response assessment during treatment than diameter-based measurement.Keywords
This publication has 28 references indexed in Scilit:
- A statistical simulation study finds discordance between WHO criteria and RECIST guidelineJournal of Clinical Epidemiology, 2004
- Measuring the clinical response. What does it mean?European Journal Of Cancer, 2002
- Clinical assessment by MRI for patients with Stage II cervical carcinoma treated by radiation alone in multicenter analysis: are all patients with Stage II disease suitable candidates for chemoradiotherapy?International Journal of Radiation Oncology*Biology*Physics, 2002
- Usefulness of tumor volumetry by magnetic resonance imaging in assessing response to radiation therapy in carcinoma of the uterine cervixInternational Journal of Radiation Oncology*Biology*Physics, 1996
- The tumor voluem and clonogen number relationship: Tumor control predictions based upon tumor volume estimates derived from computed tomographyInternational Journal of Radiation Oncology*Biology*Physics, 1995
- The influence of quantitative tumor volume measurements on local control in advanced head and neck cancer using concomitant boost accelerated superfractionated irradiationInternational Journal of Radiation Oncology*Biology*Physics, 1995
- The influence of tumor size and morphology on the outcome of patients with figo stage IB squamous cell carcinoma of the uterine cervixInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Can pretreatment computed tomography findings predict local control in T3 squamous cell carcinoma of the glottic larynx treated with radiotherapy alone?International Journal of Radiation Oncology*Biology*Physics, 1993
- Staging of carcinoma of the uterine cervix: MRI-surgical correlationClinical Radiology, 1989
- Magnetic resonance imaging in cervical cancer: A basis for objective classificationGynecologic Oncology, 1989